Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 9,000 shares at $51.46 ($464K) on 2026-07-01, disclosed to the SEC on 2026-07-01.
Scheduled sale ($464k) by EVP R&D, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.46 | 8,300 | $427K | 92.1% |
| 2 | $52.13 | 700 | $36K | 7.9% |
| Total | $51.51 avg | 9,000 | $464K | 100% |
| Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |
| ALKS | SELL | 2026-04-01 | $320K | — | Filing → |